Abstract
AbstractClinical symptoms of diabetes‐related complications are very rare in children and adolescents with type 1 diabetes (T1D). Screening for complications aims to detect their presence shortly after development but before they cause clinically significant symptoms. Early detection of complications, alongside efforts to improve glycaemic control, can slow the progression of microvascular complications with consequently improved quality of life and life expectancy. An ideal screening programme should be evidence based and should include the majority of clinically important complications and associated diseases. Such programmes have been formulated by multidisciplinary bodies representing a number of specialist diabetes societies worldwide.The purpose of this review is to highlight the importance of screening for diabetes complications and comorbidities in T1D in childhood and to review and compare the latest guidelines of the International Society for Pediatric and Adolescent Diabetes, American Diabetes Association, Canadian Diabetes Association, Australian Government National Health and Medical Research Council, and the UK National Institute for Health and Clinical Excellence. Copyright © 2011 John Wiley & Sons.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
